शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEEMMESSAR BIOTECH & NUTRITION L· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 4 Sept, 2026 · 17:49 IST

Annual Report and AGM Notice for FY2025-26 submitted

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.3%Reaction day
₹23.71
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+3.8% vs market
Commodity Chemicals peers, median of 60sector-0.1%+4.4% vs sector

On the reaction day the stock moved 3.8 pts more than Nifty Microcap 250 and 4.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.3+0.4+3.8-0.1+4.4
Next day
+4.3+0.9+3.4+0.5+3.8
2d
+3.8+0.8+3.0-0.1+4.0
3d
+3.3+0.6+2.7-0.9+4.2
4d
-0.5+0.7-1.2-0.8+0.3
5d
-0.5-2.6+2.1-1.2+0.8
1w
+1.2-1.9+3.1-2.0+3.3
15d
-1.3-0.6-0.8-1.3-0.0
1m
-0.8-1.0+0.3-1.4+0.6
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emmessar Biotech & Nutrition has submitted its 34th Annual Report and AGM Notice for FY 2025-26 under SEBI Regulation 34(1). The 34th AGM is scheduled for September 29, 2026 via video conferencing. Agenda includes adopting FY26 audited financials, re-appointing director Mr. Jeyavel Nadar by rotation, and 5-year re-appointments of MD Mr. Srinivasa Raghavan and Whole-time Director Mr. Jeyavel Nadar. MD pay scale Rs 2.2L to 4L per month, WTD pay scale Rs 1.2L to 2.5L per month.

Likely market impact

Routine annual filing. Shareholders will vote on FY26 accounts and director re-appointments at the September 29, 2026 AGM. No major operational impact.